SB

Sunindita Biswas

Active Director Director DIN 11569562
DIN 11569562 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunindita Biswas

Data last updated:

Sunindita Biswas is a Director at Novagen Pharmaceuticals India Private Limited (since 2026). The company operates in Pharma.

DIN 11569562
Primary Designation Director
Industry Pharma
First Appointment 25 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Feb 20262026Active

Board colleagues of Sunindita Biswas

NameDINCompanyDesignation
Saurav Biswas11569561Novagen Pharmaceuticals India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novagen Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Sunindita Biswas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunindita Biswas

Sunindita Biswas currently holds 1 directorship: Novagen Pharmaceuticals India Private Limited (Director, since 25 Feb 2026).

Sunindita Biswas was first appointed on 25 Feb 2026 as Director at Novagen Pharmaceuticals India Private Limited.

The current boards of Sunindita Biswas's companies include Saurav Biswas (Novagen Pharmaceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available